Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A patent review of Monoacylglycerol Lipase (MAGL) inhibitors (2013-2017)
Carlotta Granchi, Isabella Caligiuri, Filippo Minutolo, et al.
Expert Opinion on Therapeutic Patents (2017) Vol. 27, Iss. 12, pp. 1341-1351
Closed Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

New approaches and challenges to targeting the endocannabinoid system
Vincenzo Di Marzo
Nature Reviews Drug Discovery (2018) Vol. 17, Iss. 9, pp. 623-639
Closed Access | Times Cited: 412
Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders
Hui Deng, Weimin Li
Acta Pharmaceutica Sinica B (2019) Vol. 10, Iss. 4, pp. 582-602
Open Access | Times Cited: 139
The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?
Estefanía Moreno, Milena Čavić, Ana Krivokuća, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 110
An endocannabinoid-regulated basolateral amygdala–nucleus accumbens circuit modulates sociability
Oakleigh M. Folkes, Rita Báldi, Veronika Kondev, et al.
Journal of Clinical Investigation (2019) Vol. 130, Iss. 4, pp. 1728-1742
Open Access | Times Cited: 99
The Lipid Metabolic Landscape of Cancers and New Therapeutic Perspectives
Wenjun Wang, Ling Bai, Wei Li, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 81
Targeting Endocannabinoid Signaling: FAAH and MAG Lipase Inhibitors
Noëlle van Egmond, Verena M. Straub, Mario van der Stelt
The Annual Review of Pharmacology and Toxicology (2020) Vol. 61, Iss. 1, pp. 441-463
Open Access | Times Cited: 80
Deregulation of Lipid Metabolism: The Critical Factors in Ovarian Cancer
Zhaodong Ji, Yan Shen, Xu Feng, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 77
Pharmacological intervention of liver triacylglycerol lipolysis: The good, the bad and the ugly
Ariel D. Quiroga, Richard Lehner
Biochemical Pharmacology (2018) Vol. 155, pp. 233-241
Open Access | Times Cited: 68
Discovery of Trifluoromethyl Glycol Carbamates as Potent and Selective Covalent Monoacylglycerol Lipase (MAGL) Inhibitors for Treatment of Neuroinflammation
Laura A. McAllister, Christopher R. Butler, Scot Mente, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 7, pp. 3008-3026
Closed Access | Times Cited: 66
Cannabinoid interventions for PTSD: Where to next?
Luke J. Ney, Allison Matthews, Raimondo Bruno, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2019) Vol. 93, pp. 124-140
Closed Access | Times Cited: 61
2-Arachidonoylglycerol Modulation of Anxiety and Stress Adaptation: From Grass Roots to Novel Therapeutics
Gaurav Bedse, Mathew N. Hill, Sachin Patel
Biological Psychiatry (2020) Vol. 88, Iss. 7, pp. 520-530
Open Access | Times Cited: 54
Optimization of a Benzoylpiperidine Class Identifies a Highly Potent and Selective Reversible Monoacylglycerol Lipase (MAGL) Inhibitor
Carlotta Granchi, Margherita Lapillo, Sandra Glasmacher, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 4, pp. 1932-1958
Open Access | Times Cited: 53
Inhibitors of lipogenic enzymes as a potential therapy against cancer
Nicolás Montesdeoca, M. Allué López, Xavier Ariza, et al.
The FASEB Journal (2020) Vol. 34, Iss. 9, pp. 11355-11381
Open Access | Times Cited: 47
A Highly Selective and Versatile Probe Platform for Visualization of Monoacylglycerol Lipase
Axel Hentsch, Mónica Guberman, Silke Radetzki, et al.
Angewandte Chemie International Edition (2025)
Open Access
A Highly Selective and Versatile Probe Platform for Visualization of Monoacylglycerol Lipase
Axel Hentsch, Mónica Guberman, Silke Radetzki, et al.
Angewandte Chemie (2025)
Open Access
Highly Specific Miniaturized Fluorescent Monoacylglycerol Lipase Probes Enable Translational Research
Axel Hentsch, Mónica Guberman, Silke Radetzki, et al.
Journal of the American Chemical Society (2025)
Open Access
α/β-Hydrolase Domain (ABHD) Inhibitors as New Potential Therapeutic Options against Lipid-Related Diseases
Giulia Bononi, Tiziano Tuccinardi, Flavio Rizzolio, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 14, pp. 9759-9785
Open Access | Times Cited: 32
Design and Synthesis of Novel Spiro Derivatives as Potent and Reversible Monoacylglycerol Lipase (MAGL) Inhibitors: Bioisosteric Transformation from 3-Oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl Moiety
Shuhei Ikeda, Hideyuki Sugiyama, Hidekazu Tokuhara, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 15, pp. 11014-11044
Open Access | Times Cited: 28
Targeting Monoacylglycerol Lipase in Pursuit of Therapies for Neurological and Neurodegenerative Diseases
Anca Zanfirescu, Anca Ungurianu, Dragoș Paul Mihai, et al.
Molecules (2021) Vol. 26, Iss. 18, pp. 5668-5668
Open Access | Times Cited: 27
Development of High Brain-Penetrant and Reversible Monoacylglycerol Lipase PET Tracers for Neuroimaging
Yingfang He, Matthias Schild, Uwe Grether, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 3, pp. 2191-2207
Closed Access | Times Cited: 21
Radiolabelling small and biomolecules for tracking and monitoring
Martin R. Edelmann
RSC Advances (2022) Vol. 12, Iss. 50, pp. 32383-32400
Open Access | Times Cited: 20
Computationally driven discovery of phenyl(piperazin-1-yl)methanone derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors
Giulio Poli, Margherita Lapillo, Vibhu Jha, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2019) Vol. 34, Iss. 1, pp. 589-596
Open Access | Times Cited: 34
Novel therapies for glaucoma: a patent review (2013-2019)
Paolo Guglielmi, Simone Carradori, Cristina Campestre, et al.
Expert Opinion on Therapeutic Patents (2019) Vol. 29, Iss. 10, pp. 769-780
Open Access | Times Cited: 32
An updated patent review of monoacylglycerol lipase (MAGL) inhibitors (2018-present)
Giulia Bononi, Giulio Poli, Flavio Rizzolio, et al.
Expert Opinion on Therapeutic Patents (2020) Vol. 31, Iss. 2, pp. 153-168
Closed Access | Times Cited: 31
Recent Advances in Endocannabinoid System Targeting for Improved Specificity: Strategic Approaches to Targeted Drug Delivery
Mendhi Henna Dasram, Roderick B. Walker, Sandile M. Khamanga
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13223-13223
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top